| P50 | author | Koji Uotani | Q87677403 |
| | Aki Yoshida | Q87677406 |
| | Takahiro Ochiya | Q89401456 |
| P2093 | author name string | Ken Takeda | |
| | Tomohiro Fujiwara | |
| | Toshifumi Ozaki | |
| | Toshiyuki Kunisada | |
| P2860 | cites work | MicroRNA expression signature of human sarcomas | Q47836377 |
| | Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases | Q50118892 |
| | Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C | Q24554516 |
| | Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells | Q24555724 |
| | Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells | Q24632284 |
| | MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development | Q24648202 |
| | A viral microRNA functions as an orthologue of cellular miR-155 | Q24652947 |
| | Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155 | Q24681400 |
| | Oncomirs - microRNAs with a role in cancer | Q27860773 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma | Q28251930 |
| | Causes and consequences of microRNA dysregulation in cancer | Q28258994 |
| | Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma | Q28304953 |
| | Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 |
| | Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis. | Q51091546 |
| | Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. | Q51742862 |
| | MicroRNA therapeutics in preclinical cancer models. | Q51874073 |
| | Epithelioid sarcoma | Q56866362 |
| | Synovial sarcoma of children and adolescents: The prognostic role of axial sites | Q59377179 |
| | Telomerase activity in soft-tissue and bone sarcomas | Q73393191 |
| | Prognostic factors for patients with sarcomas of the pelvic bones | Q74256533 |
| | Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study | Q74606192 |
| | Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer | Q83316012 |
| | Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma | Q83692402 |
| | MicroRNA-21 is involved in osteosarcoma cell invasion and migration | Q84245716 |
| | The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility | Q84470156 |
| | Identification of altered MicroRNA expression patterns in synovial sarcoma | Q39611039 |
| | Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma | Q39669508 |
| | MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. | Q39692795 |
| | Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network | Q40025792 |
| | Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor | Q40300474 |
| | Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma | Q40691537 |
| | TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma | Q42830481 |
| | Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis | Q43455742 |
| | Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients | Q43568993 |
| | Epithelioid sarcoma: results of conservative surgery and radiotherapy. | Q43704828 |
| | Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution | Q44830728 |
| | Prognostic determinants in epithelioid sarcoma. | Q44849210 |
| | Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases | Q46793490 |
| | MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 |
| | Identification of microRNAs of the herpesvirus family | Q29618671 |
| | Modulation of microRNA processing by p53 | Q29620776 |
| | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression | Q30537249 |
| | Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression | Q33273626 |
| | Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. | Q33432690 |
| | MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation | Q33528956 |
| | Adult-type Fibrosarcoma: A Reevaluation of 163 Putative Cases Diagnosed at a Single Institution Over a 48-year Period | Q33688909 |
| | Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours | Q33758070 |
| | Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus | Q33883910 |
| | MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas | Q33906031 |
| | Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma | Q33938849 |
| | Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development | Q33997274 |
| | A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy | Q34033361 |
| | Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis | Q34125617 |
| | The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification | Q34181123 |
| | Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment | Q34198881 |
| | EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis | Q34199631 |
| | Epithelioid sarcoma.A sarcoma simulating a granuloma or a carcinoma | Q34234575 |
| | EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. | Q34283431 |
| | Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee. | Q34476210 |
| | A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses | Q34547697 |
| | Differential sensitivity of liposarcoma subtypes to chemotherapy | Q34562627 |
| | Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses | Q34571535 |
| | Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis | Q34693160 |
| | Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group | Q34694293 |
| | Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness | Q34715623 |
| | TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. | Q34799828 |
| | MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression | Q35086698 |
| | Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas | Q35743203 |
| | miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. | Q35783986 |
| | MicroRNA Involvement in Osteosarcoma | Q35898407 |
| | MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors | Q36127420 |
| | The evolving classification of soft tissue tumours: an update based on the new WHO classification | Q36344264 |
| | Kaposi's sarcoma and its associated herpesvirus | Q36487309 |
| | MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression | Q36746921 |
| | Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival | Q36898111 |
| | OncomiRs: the discovery and progress of microRNAs in cancers | Q36951319 |
| | Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma | Q37237479 |
| | The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation | Q37286651 |
| | NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma | Q37311506 |
| | Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? | Q37325228 |
| | MicroRNAs of Kaposi's sarcoma-associated herpes virus | Q37327019 |
| | The management of soft tissue sarcoma | Q37335687 |
| | miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. | Q37428692 |
| | miR-21 as a key regulator of oncogenic processes | Q37554678 |
| | Molecular and cellular biology of rhabdomyosarcoma. | Q37630588 |
| | Targets for cancer therapy in childhood sarcomas | Q37707632 |
| | MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality | Q37937737 |
| | The roles of microRNAs in sarcomas | Q38001369 |
| | MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis. | Q38118222 |
| | The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification | Q38155908 |
| | MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development | Q38212020 |
| | miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin | Q38325863 |
| | MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). | Q38325925 |
| | Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis | Q38327383 |
| | MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration | Q38338974 |
| | S-MED: sarcoma microRNA expression database | Q38431264 |
| | SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels | Q39044548 |
| | Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma. | Q39144774 |
| | Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. | Q39273744 |
| | Circulating microRNAs as novel minimally invasive biomarkers for breast cancer | Q39281588 |
| | MicroRNA profiling of primary high-grade soft tissue sarcomas | Q39312145 |
| | A novel target of microRNA-29, Ring1 and YY1-binding protein (Rybp), negatively regulates skeletal myogenesis | Q39337764 |
| | MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling | Q39393414 |
| | Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma | Q39397196 |
| | miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells | Q39427500 |
| | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sarcoma | Q223911 |
| | microRNA | Q310899 |
| | biomarker | Q864574 |
| | tumor biomarker | Q66205818 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 592868 | |
| P577 | publication date | 2014-08-04 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers | |
| P478 | volume | 2014 | |